Small study, big results for Type I diabetes.
Small study, big results for Type I diabetes. “Zimislecel is an allogeneic stem cell–derived islet-cell therapy. … Ten of the 12 participants (83%) had insulin independence and were not using exogenous insulin at day 365.” ~ learn more